Abbott's new ablation catheter is approved by the FDA for precise treatment of complex arrhythmias
Release date: 2017-03-06
Today, Abbott announced that the FlexAbility ablation catheter that matches the sensor has been approved by the US FDA to improve the versatility and precision of cardiac ablation surgery for atrial flutter (a type of irregular heartbeat). After this approval, the company has further expanded its electrophysiological portfolio to benefit patients with abnormal heart rhythms (arrhythmia).
Ablation catheters are used to help treat patients with irregular heartbeats, which are medically known as arrhythmias. Arrhythmias can cause symptoms such as palpitations and dizziness, and even cause stroke or cardiac arrest. During an ablation procedure, the catheter delivers energy to the heart tissue, creating a small area of ​​scarring or damage to the area responsible for the arrhythmia. The purpose of mediating these injuries is to prevent abnormal electrical signals from entering the heart, which is expected to restore the heart to rhythm.
This sensor-matched FlexAbility ablation catheter is Abbott's first ablation catheter product that collects current resistance (impedance) and permeability data for detailed and accurate mapping, helping to trigger or maintain abnormal heart rhythm treatment . It is also ABB's second Enabled Sensor tool in the United States, inheriting the company's EnSite Precision cardiac mapping system, which also includes sensor-matched Advisor FL ring mapping catheter products.
When used with the EnSite Precision cardiac mapping system, the sensor-matched catheter allows the physician to create a highly detailed 3-dimensional heart model that overlays the electrophysiological activity of the heart. These models help doctors identify the type of arrhythmia and the area they should treat with an ablation catheter. The catheter is also compatible with Abbott's MediGuide technology, allowing doctors to reduce the duration of actual X-rays during surgery.
The sensor-matched FlexAbility ablation catheter is based on the original FlexAbility ablation catheter technology platform and features a first perfusion flexible tip that provides directional flow and tip temperature monitoring to reduce surgical risk. The new enhanced version of the sensor-matched FlexAbility ablation catheter increases the ability to collect permeance data and provides program versatility and precision when integrated with Abbott's drawing navigation system.
Dr. Srijoy Mahapatra, Medical Director of Abbott's Electrophysiology Business, said: "We will continue to innovate around the EnSite Precision cardiac mapping system to create a combination of ablation technologies that are best suited for physicians seeking to address the most severe cases. The launch of activating ablation catheters is positive This is met: especially when doctors encounter complex situations, it provides the ability to engage magnetic platforms to improve accuracy."
Source: Chuangjianhui
Canned Grapefruit Sacs, Ruby Grapefruits, Canned White Grapefruit, Canned Grapefruit Segments, Canned Red Grapefruit, Fresh Grapefruit
ZHEJIANG FOMDAS FOODS CO., LTD. , https://www.fomdasfoods.com